These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones. Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835 [TBL] [Abstract][Full Text] [Related]
29. Phenoxyethyl Piperidine/Morpholine Derivatives as PAS and CAS Inhibitors of Cholinesterases: Insights for Future Drug Design. Pourshojaei Y; Abiri A; Eskandari K; Haghighijoo Z; Edraki N; Asadipour A Sci Rep; 2019 Dec; 9(1):19855. PubMed ID: 31882733 [TBL] [Abstract][Full Text] [Related]
30. Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors. Campiani G; Fattorusso C; Butini S; Gaeta A; Agnusdei M; Gemma S; Persico M; Catalanotti B; Savini L; Nacci V; Novellino E; Holloway HW; Greig NH; Belinskaya T; Fedorko JM; Saxena A J Med Chem; 2005 Mar; 48(6):1919-29. PubMed ID: 15771436 [TBL] [Abstract][Full Text] [Related]
31. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors. Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396 [TBL] [Abstract][Full Text] [Related]
32. Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease. Pudlo M; Luzet V; Ismaïli L; Tomassoli I; Iutzeler A; Refouvelet B Bioorg Med Chem; 2014 Apr; 22(8):2496-507. PubMed ID: 24657052 [TBL] [Abstract][Full Text] [Related]
33. Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesterase. Villalobos A; Blake JF; Biggers CK; Butler TW; Chapin DS; Chen YL; Ives JL; Jones SB; Liston DR; Nagel AA J Med Chem; 1994 Aug; 37(17):2721-34. PubMed ID: 8064800 [TBL] [Abstract][Full Text] [Related]
34. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling. Feng B; Li X; Xia J; Wu S J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678 [TBL] [Abstract][Full Text] [Related]
35. Structure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE/BuChE inhibitors for Alzheimer's disease. Conceição RAD; von Ranke N; Azevedo L; Franco D; Nadur NF; Kummerle AE; Barbosa MLC; Souza AMT J Cell Biochem; 2023 Nov; 124(11):1734-1748. PubMed ID: 37796142 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors. Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates. Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. Shao D; Zou C; Luo C; Tang X; Li Y Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches. Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids. Zurek E; Szymański P; Mikiciuk-Olasik E Drug Res (Stuttg); 2013 Mar; 63(3):137-44. PubMed ID: 23447117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]